Sign In
Buy CORT
$72.65
+1.45 (+2.04%)
At Close: Jun 03, 2026
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of inve
CORT Investors with Losses Encouraged to Contact the Firm SAN FRANCISCO, Feb. 26, 2026 /PRNewswire/ -- National shareholder rights law firm Hagens Berman is notifying investors that a securities class
SAN DIEGO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Corcept Therapeutics Incorpo
NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Corcept Therapeutics Incorporated (“Corcept” or the “Company”) (NAS
NEW ORLEANS, Feb. 25, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until April 21, 2026 to file lead plaintiff applications in a secur
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Corcept Therapeutics Incorporated (“Corcept�
New York, New York--(Newsfile Corp. - February 25, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Corcept T
SAN DIEGO, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Corcept Therapeutics Incorporated (NASDAQ: CORT) common stock between October 31
SAN FRANCISCO, Feb. 25, 2026 (GLOBE NEWSWIRE) -- National shareholder rights law firm Hagens Berman is notifying investors that a securities class action lawsuit has been filed against Corcept Therape
Corcept's Q4 Earnings and Revenues Fall Short of Estimates
10:15am, Wednesday, 25'th Feb 2026
CORT misses Q4 earnings and revenue estimates despite 11% sales growth year over year.
Corcept Therapeutics Incorporated Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – CORT
07:15am, Wednesday, 25'th Feb 2026
LOS ANGELES--(BUSINESS WIRE)--Corcept Therapeutics Incorporated Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – CORT.
Corcept Therapeutics (CORT) Q4 Earnings and Revenues Miss Estimates
10:55pm, Tuesday, 24'th Feb 2026
Corcept Therapeutics (CORT) came out with quarterly earnings of $0.2 per share, missing the Zacks Consensus Estimate of $0.27 per share. This compares to earnings of $0.26 per share a year ago.
CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit with the Schall Law Firm
10:03pm, Tuesday, 24'th Feb 2026
LOS ANGELES--(BUSINESS WIRE)---- $CORT--CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit with the Schall Law Firm.
NEW YORK, and NEW ORLEANS, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with subst
Corcept Therapeutics Incorporated (CORT) Q4 2025 Earnings Call Transcript
07:47pm, Tuesday, 24'th Feb 2026
Corcept Therapeutics Incorporated (CORT) Q4 2025 Earnings Call Transcript
